Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 14, Number 11—November 2008
Dispatch

Novel Human Rhinoviruses and Exacerbation of Asthma in Children1

Nino Khetsuriani, Xiaoyan Lu, W. Gerald Teague, Neely Kazerouni2, Larry J. Anderson, and Dean D. ErdmanComments to Author 
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (N. Khetsuriani, X. Lu, N. Kazerouni, L.J. Anderson, D.D. Erdman); Emory University School of Medicine, Atlanta (W.G. Teague);

Main Article

Table 1

Criteria and definitions used in the study of children with asthma, March 2003–February 2004 (10)

Category Criteria
Current persistent asthma:
In children 2–5 y of age All of the following:
1. Physician diagnosis of asthma
2. >2 previous episodes of cough, wheeze, and/or respiratory distress
3. Current treatment with asthma medications
4. Parent or sibling with current or past diagnosis of asthma or allergy, and/or current or past 
evidence of atopy (defined by seasonal rhinitis, eczema, or food hypersensitivity)
In children 6–17 y of age
 All of the following:
1. Physician diagnosis of asthma
2. Symptoms of asthma in the past 12 mo
3. Current treatment with asthma medications
Case (asthma exacerbation)
 Current persistent asthma, hospital admission or clinic visit for asthma exacerbation, and all of the following:
1. Signs and symptoms of airflow obstruction (i.e., cough, wheeze, shortness of breath, chest 
tightness) within past 48 h
2. Increased asthma symptoms resulting in hospital admission or clinic visit
3. Repeated use of short-acting β-agonists within past 48 h
4. Increased dose or addition of a new asthma controller therapy within past wk
Control (well-controlled asthma)
 Current persistent asthma, routine clinic visit for asthma, and all of the following:
1. No systemic steroid therapy in past 4 wk
2. No increase in dose and no new controller medications in past wk
3. No change in the frequency of use of short-acting rescue medications in past wk
4. No increase in asthma symptom frequency in past wk
Acute respiratory viral illness >2 of the following: fever, stuffy/runny nose, headache, muscle aches, and pain or redness of eye(s) at the time of clinic visit or hospital admission

Main Article

References
  1. Gern  JE, Busse  WW. Association of rhinovirus infections with asthma. Clin Microbiol Rev. 1999;12:9–18.PubMedGoogle Scholar
  2. Ledford  RM, Patel  NR, Demenczuk  TM, Watanyar  A, Herbertz  T, Collett  MS, VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds. J Virol. 2004;78:3663–74. DOIPubMedGoogle Scholar
  3. Laine  P, Savolainen  C, Blomqvist  S, Hovi  T. Phylogenetic analysis of human rhinovirus capsid protein VP1 and 2A protease coding sequences confirms shared genus-like relationships with human enteroviruses. J Gen Virol. 2005;86:697–706. DOIPubMedGoogle Scholar
  4. McErlean  P, Shackelton  LA, Lambert  SB, Nissen  MD, Sloots  TP, Mackay  IM. Characterisation of a newly identified human rhinovirus, HRV-QPM, discovered in infants with bronchiolitis. J Clin Virol. 2007;39:67–75. DOIPubMedGoogle Scholar
  5. Lamson  D, Renwick  N, Kapoor  V, Liu  Z, Palacios  G, Ju  J, MassTag polymerase-chain-reaction detection of respiratory pathogens, including a new rhinovirus genotype, that caused influenza-like illness in New York State during 2004–2005. J Infect Dis. 2006;194:1398–402. DOIPubMedGoogle Scholar
  6. Lau  SK, Yip  CC, Tsoi  HW, Lee  RA, So  LY, Lau  YL, Clinical features and complete genome characterization of a distinct human rhinovirus (HRV) genetic cluster, probably representing a previously undetected HRV species, HRV-C, associated with acute respiratory illness in children. J Clin Microbiol. 2007;45:3655–64. DOIPubMedGoogle Scholar
  7. Lee  WM, Kiesner  C, Pappas  T, Lee  I, Grindle  K, Jartti  T, A diverse group of previously unrecognized human rhinoviruses are common causes of respiratory illnesses in infants. PLoS One. 2007;2:e966. DOIPubMedGoogle Scholar
  8. Kistler  A, Avila  PC, Rouskin  S, Wang  D, Ward  T, Yagi  S, Pan-viral screening of respiratory tract infections in adults with and without asthma reveals unexpected human coronavirus and human rhinovirus diversity. J Infect Dis. 2007;196:817–25. DOIPubMedGoogle Scholar
  9. Renwick  N, Schweiger  B, Kapoor  V, Liu  Z, Villari  J, Bullmann  R, A recently identified rhinovirus genotype is associated with severe respiratory-tract infection in children in Germany. J Infect Dis. 2007;196:1754–60. DOIPubMedGoogle Scholar
  10. Khetsuriani  N, Kazerouni  NN, Erdman  DD, Lu  X, Redd  SC, Anderson  LJ, Prevalence of viral respiratory tract infections in children with asthma. J Allergy Clin Immunol. 2007;119:314–21. DOIPubMedGoogle Scholar
  11. Swofford  DL. PAUP*: Phylogenetic analysis using parsimmony (*and other methods). Version 4. Sunderland (MA): Sinauer Associates; 2001.
  12. Andries  K, Dewindt  B, Snoeks  J, Wouters  L, Moereels  H, Lewi  PJ, Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity. J Virol. 1990;64:1117–23.PubMedGoogle Scholar
  13. Ledford  RM, Collett  MS, Pevear  DC. Insights into the genetic basis for natural phenotypic resistance of human rhinoviruses to pleconaril. Antiviral Res. 2005;68:135–8. DOIPubMedGoogle Scholar
  14. Winther  B, Hayden  FG, Hendley  JO. Picornavirus infections in children diagnosed by RT-PCR during longitudinal surveillance with weekly sampling: association with symptomatic illness and effect of season. J Med Virol. 2006;78:644–50. DOIPubMedGoogle Scholar
  15. Jartti  T, Lehtinen  P, Vuorinen  T, Koskenvuo  M, Ruuskanen  O. Persistence of rhinovirus and enterovirus RNA after acute respiratory illness in children. J Med Virol. 2004;72:695–9. DOIPubMedGoogle Scholar

Main Article

1Part of the information in this article was presented at the International Conference of the American Thoracic Society, May 16–21, 2008, Toronto, Ontario, Canada.

2Current affilation: California Department of Public Health, Richmond, California, USA.

Page created: July 18, 2010
Page updated: July 18, 2010
Page reviewed: July 18, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external